🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, double-blind, randomized, placebo-controlled phase 2...
Status
Completed
Location
Shanghai Public Health Clinical Center
Start Date
2022-01-21
Trial ID
NCT05113784
Treatments Being Tested
This Phase 1 study will be conducted to explore the dose regimen in humans ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-03
Trial ID
NCT04327310
Treatments Being Tested
This phase 2a open-label study to assess Meplazumab in adult patients diagn...
Status
Active Not Recruiting
Location
Kisumu County Referral Hospital
Start Date
2024-04-26
Trial ID
NCT06040346
Treatments Being Tested
This phase2/3 study will be conducted to evaluate the safety and efficacy o...
Status
Completed
Location
Pesquisare Saúde
Start Date
2021-02-15
Trial ID
NCT04586153
Treatments Being Tested
This is a multicenter, double-blind, randomized, placebo-controlled, loaded...
Status
Completed
Location
First Affiliated Hospital of the Air Force Medical University
Start Date
2024-01-19
Trial ID
NCT05679479
Treatments Being Tested
This is a single center, double-blinded, placebo-controlled phase I clinica...
Status
Completed
Location
Xijing Hospital of the Fourth Military Medical University
Start Date
2020-04-25
Trial ID
NCT04369586
Treatments Being Tested
This trial was a randomized, double-blind, placebo-controlled, loading phas...
Status
Completed
Location
First Affiliated Hospital of the Air Force Medical University
Start Date
2023-03-23
Trial ID
NCT05813587
Treatments Being Tested
To evaluate the safety and efficacy of humanized Meplazumab for Injection i...
Status
Completed
Location
Tangdu Hospital
Start Date
2020-02-03
Trial ID
NCT04275245
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, add-on...
Status
Withdrawn
Location
First Affiliated Hospital of the Air Force Medical University
Start Date
2023-05-30
Trial ID
NCT05679492
Treatments Being Tested